review of related literature in action research

Archer Library

Action research: literature review .

• Archer Library This link opens in a new window
• EDFN 504 • Action Research Handout This link opens in a new window
• Locating Books
• ebook Collections This link opens in a new window
• A to Z Database List This link opens in a new window
• Research & Statistics
• Literature Review Resources
• Citation & Reference

Exploring the literature review 

Literature review model: 6 steps.

Adapted from The Literature Review , Machi & McEvoy (2009, p. 13).

Your Literature Review

Step 2: search, boolean search strategies, search limiters, ★ ebsco & google drive.

1. Select a Topic

"All research begins with curiosity" (Machi & McEvoy, 2009, p. 14)

Selection of a topic, and fully defined research interest and question, is supervised (and approved) by your professor. Tips for crafting your topic include:

• Be specific. Take time to define your interest.
• Topic Focus. Fully describe and sufficiently narrow the focus for research.
• Academic Discipline. Learn more about your area of research & refine the scope.
• Avoid Bias. Be aware of bias that you (as a researcher) may have.
• Document your research. Use Google Docs to track your research process.
• Research apps. Consider using Evernote or Zotero to track your research.

Consider Purpose

What will your topic and research address?

In The Literature Review: A Step-by-Step Guide for Students , Ridley presents that literature reviews serve several purposes (2008, p. 16-17).  Included are the following points:

• Historical background for the research;
• Overview of current field provided by "contemporary debates, issues, and questions;"
• Theories and concepts related to your research;
• Introduce "relevant terminology" - or academic language - being used it the field;
• Connect to existing research - does your work "extend or challenge [this] or address a gap;" 
• Provide "supporting evidence for a practical problem or issue" that your research addresses.

★ Schedule a research appointment

At this point in your literature review, take time to meet with a librarian. Why? Understanding the subject terminology used in databases can be challenging. Archer Librarians can help you structure a search, preparing you for step two. How? Contact a librarian directly or use the online form to schedule an appointment. Details are provided in the adjacent Schedule an Appointment box.

2. Search the Literature

Collect & Select Data: Preview, select, and organize

AU Library is your go-to resource for this step in your literature review process. The literature search will include books and ebooks, scholarly and practitioner journals, theses and dissertations, and indexes. You may also choose to include web sites, blogs, open access resources, and newspapers. This library guide provides access to resources needed to complete a literature review.

Books & eBooks: Archer Library & OhioLINK

Databases: scholarly & practitioner journals.

Review the Library Databases tab on this library guide, it provides links to recommended databases for Education & Psychology, Business, and General & Social Sciences.

Expand your journal search; a complete listing of available AU Library and OhioLINK databases is available on the Databases  A to Z list . Search the database by subject, type, name, or do use the search box for a general title search. The A to Z list also includes open access resources and select internet sites.

Databases: Theses & Dissertations

Review the Library Databases tab on this guide, it includes Theses & Dissertation resources. AU library also has AU student authored theses and dissertations available in print, search the library catalog for these titles.

Did you know? If you are looking for particular chapters within a dissertation that is not fully available online, it is possible to submit an ILL article request . Do this instead of requesting the entire dissertation.

Newspapers:  Databases & Internet

Consider current literature in your academic field. AU Library's database collection includes The Chronicle of Higher Education and The Wall Street Journal .  The Internet Resources tab in this guide provides links to newspapers and online journals such as Inside Higher Ed , COABE Journal , and Education Week .

Search Strategies & Boolean Operators

There are three basic boolean operators:  AND, OR, and NOT.

Used with your search terms, boolean operators will either expand or limit results. What purpose do they serve? They help to define the relationship between your search terms. For example, using the operator AND will combine the terms expanding the search. When searching some databases, and Google, the operator AND may be implied.

Overview of boolean terms

About the example: Boolean searches were conducted on November 4, 2019; result numbers may vary at a later date. No additional database limiters were set to further narrow search returns.

Database Search Limiters

Database strategies for targeted search results.

Most databases include limiters, or additional parameters, you may use to strategically focus search results.  EBSCO databases, such as Education Research Complete & Academic Search Complete provide options to:

• Limit results to full text;
• Limit results to scholarly journals, and reference available;
• Select results source type to journals, magazines, conference papers, reviews, and newspapers
• Publication date

Keep in mind that these tools are defined as limiters for a reason; adding them to a search will limit the number of results returned.  This can be a double-edged sword.  How? 

• If limiting results to full-text only, you may miss an important piece of research that could change the direction of your research. Interlibrary loan is available to students, free of charge. Request articles that are not available in full-text; they will be sent to you via email.
• If narrowing publication date, you may eliminate significant historical - or recent - research conducted on your topic.
• Limiting resource type to a specific type of material may cause bias in the research results.

Use limiters with care. When starting a search, consider opting out of limiters until the initial literature screening is complete. The second or third time through your research may be the ideal time to focus on specific time periods or material (scholarly vs newspaper).

★ Truncating Search Terms

Expanding your search term at the root.

Truncating is often referred to as 'wildcard' searching. Databases may have their own specific wildcard elements however, the most commonly used are the asterisk (*) or question mark (?).  When used within your search. they will expand returned results.

Asterisk (*) Wildcard

Using the asterisk wildcard will return varied spellings of the truncated word. In the following example, the search term education was truncated after the letter "t."

Explore these database help pages for additional information on crafting search terms.

• EBSCO Connect: Searching with Wildcards and Truncation Symbols
• EBSCO Connect: Searching with Boolean Operators
• EBSCO Connect: EBSCOhost Search Tips
• EBSCO Connect: Basic Searching with EBSCO
• ProQuest Help: Search Tips
• ERIC: How does ERIC search work?

★ EBSCO Databases & Google Drive

Tips for saving research directly to Google drive.

Researching in an EBSCO database?

It is possible to save articles (PDF and HTML) and abstracts in EBSCOhost databases directly to Google drive. Select the Google Drive icon, authenticate using a Google account, and an EBSCO folder will be created in your account. This is a great option for managing your research. If documenting your research in a Google Doc, consider linking the information to actual articles saved in drive.

EBSCO Databases & Google Drive

EBSCOHost Databases & Google Drive: Managing your Research

This video features an overview of how to use Google Drive with EBSCO databases to help manage your research. It presents information for connecting an active Google account to EBSCO and steps needed to provide permission for EBSCO to manage a folder in Drive.

About the Video:  Closed captioning is available, select CC from the video menu.  If you need to review a specific area on the video, view on YouTube and expand the video description for access to topic time stamps.  A video transcript is provided below.

• EBSCOhost Databases & Google Scholar

Defining Literature Review

What is a literature review.

A definition from the Online Dictionary for Library and Information Sciences .

A literature review is "a comprehensive survey of the works published in a particular field of study or line of research, usually over a specific period of time, in the form of an in-depth, critical bibliographic essay or annotated list in which attention is drawn to the most significant works" (Reitz, 2014). 

A systemic review is "a literature review focused on a specific research question, which uses explicit methods to minimize bias in the identification, appraisal, selection, and synthesis of all the high-quality evidence pertinent to the question" (Reitz, 2014).

Recommended Reading

About this page

EBSCO Connect [Discovery and Search]. (2022). Searching with boolean operators. Retrieved May, 3, 2022 from https://connect.ebsco.com/s/?language=en_US

EBSCO Connect [Discover and Search]. (2022). Searching with wildcards and truncation symbols. Retrieved May 3, 2022; https://connect.ebsco.com/s/?language=en_US

Machi, L.A. & McEvoy, B.T. (2009). The literature review . Thousand Oaks, CA: Corwin Press: 

Reitz, J.M. (2014). Online dictionary for library and information science. ABC-CLIO, Libraries Unlimited . Retrieved from https://www.abc-clio.com/ODLIS/odlis_A.aspx

Ridley, D. (2008). The literature review: A step-by-step guide for students . Thousand Oaks, CA: Sage Publications, Inc.

Archer Librarians

Schedule an appointment.

Contact a librarian directly (email), or submit a request form. If you have worked with someone before, you can request them on the form.

• ★ Archer Library Help • Online Reqest Form
• Carrie Halquist • Reference & Instruction
• Jessica Byers • Reference & Curation
• Don Reams • Corrections Education & Reference
• Diane Schrecker • Education & Head of the IRC
• Tanaya Silcox • Technical Services & Business
• Sarah Thomas • Acquisitions & ATS Librarian
• << Previous: Research & Statistics
• Next: Literature Review Resources >>
• Last Updated: Apr 23, 2024 3:23 PM
• URL: https://libguides.ashland.edu/action-research

Archer Library • Ashland University © Copyright 2023. An Equal Opportunity/Equal Access Institution.

Want to create or adapt books like this? Learn more about how Pressbooks supports open publishing practices.

3 Planning Your Research: Reviewing the Literature and Developing Questions

ESSENTIAL QUESTIONS

• What is relevant literature? What are the best ways to find it?
• What are the best ways to organize your relevant literature?
• What are the intended outcomes of reviewing your relevant literature?

Nearly all research begins with a review of literature that is relevant to the topic of research, even if it is only a casual review. Reviewing the available literature on your topic is a vital step in the research process. The literature review process provides an anchor for your inquiry. O’Leary (2004, p. 66) states, the “production of new knowledge is fundamentally dependent on past knowledge” because “it is virtually impossible for researchers to add to a body of literature if they are not conversant with it.” By reviewing the literature in the initial stages of the inquiry process, researchers are better able to:

• Understand their topic;
• Develop and focus a topic;
• Provide a clear rationale for, or better situate, their topic;
• Fine-tune their research questions.

In terms of thinking about methodology and the actual research process, reviewing the literature can help researchers:

• Identify well-vetted data collection and analysis methods on their topic;
• Determine whether to replicate a previous study, or develop a completely new study;
• Add rigor and validity to the research by validating the topic, methods, and significance.

Lastly, reviewing the literature also helps the researcher make sense of their findings, in both their field of study and in their educational context, by:

• Assessing whether the findings correlate with findings from another study;
• Determining which of the findings are different than previous studies;
• Determining which of the findings are unique to the researcher’s educational context. [1]

As you may see, the literature review is the backbone, anchor, or foundation of your research study. Overall the review of literature helps you answer three important questions that are the result of the bullet points outlined above. The literature review helps you answer the following:

• What do we know about your topic?
• What do we not know about your topic?
• How does your research address the gap between what we know and what we don’t about your topic?

After reviewing the literature, if you are able to answer those three questions, you will have a very clear and well-rationalized justification for your inquiry. If you cannot answer those questions, then you should probably keep reviewing the literature by looking for related topics or synonyms of major concepts.

While an extensive review of the literature about your topic of study is expected, you should also be realistic as to what you are able to manage. For topics that have a lot of research literature available, make sure you establish parameters for your research, such as:

• Temporal (e.g., only articles in the last 5 or 10 years)
• Content Area (e.g., only in science and math classrooms)
• Age or grade (e.g., only middle school classrooms)
• Research Subject (e.g., girls only, teachers, struggling readers)

These categories provide only a few examples, but parameters like these can make your review of literature much more manageable and your study much more focused.

What Types of Literature Should You Consider in Your Review?

It is helpful to consider the characteristics, purposes, and outcomes of different types of literature. Below are four broad categories I identify within educational research literature. I want to emphasize that my categories are in no way definitive, and only represent my own understanding.

Policy-Based Literature

Policy-based literature includes official documents that outline education policy with which the practitioner needs to be familiar. For example, the Common Core Standards or Content Standards are often refenced in articles to situate the need for research in relation to the standards; if my topic was on place-based education with middle school social studies students, I might have to look at national social studies standards. There also may be initiatives launched by organizations or researchers that become accepted practice. The documents that launch these initiatives (e.g., reports, articles, speeches) would also be useful to review. An example would be the Report of the National Reading Panel: Teaching Children to Read report from the National Reading Panel. These documents may provide rationale, based on the theories and concepts they utilize, and they may provide new ways of thinking about your topic. Similarly, if your topic is based on the local context, recent newspaper articles could also provide policy-type insights. All of these policy-based insights will be useful in providing the landscape or background for your work.

Theoretical Literature

Once you have identified your theoretical perspective, it is also important to locate your research within the appropriate theoretical literature. Many of you may be engaged in highly practice-based or small-scale research and wonder if you need a theoretical basis in your literature review. Regardless of the extent of your project, theoretical literature will help with the rigor and validity of your study and will help identify any theoretical views that underlie your topic. For example, if your study focuses on the place-based education in enhancing social studies students’ learning, it is highly probable that you would cite Kolb’s (1984/2014) work on Experiential Learning. By using Kolb’s work, you situate your research theoretically in the area of experiential learning.

Applicable Literature

Applicable literature will account for the bulk of your literature review. The previous two types of literature provide indication as to where your research is rationalized professionally and situated theoretically. Applicable literature will mainly come from journals related to your specific field of study. If I was doing a study in a social studies classroom, I would look at the journals The Social Studies, Social Education, and Social Studies Research and Practice . Use Google Scholar or your university library databases to examine literature in your specific area. When using these search engines and databases, start as specific as possible with your topic and related concepts. Using the example of place-based learning from above, I would search for “place-based learning” and “social studies” and “middle school” and “historic sites”. If I did not find many articles with this first search, then I would remove “historic sites” and search again. Books or handbooks on research may also have some useful studies to support your literature review section.

Methodological Literature

When sharing or reporting your work, you will want to review and cite research methodology literature to justify the methods you chose. When reading other research articles, pay attention to the research methods used by researchers. It is especially important to find articles that use and cite action research methodology. This type of literature will provide further support of your data gathering and analysis methods. Again, your methods should fit within your theoretical and epistemological stances. In addition, you’ll want to review data collection methods and potentially borrow or adapt rubrics or surveys from other studies.

Sources of Relevant Literature

When searching for these four types of literature, there are two ways to think about possible sources:

• primary sources include government publications, policy documents, research papers, dissertations, conference presentations and institutional occasional papers with accounts of research;
• secondary sources use primary sources as references, such as papers written for professional conferences and journals, books written for practicing professionals and book reviews. This is often called “reference mining” as you look through the reference lists of other studies and then return to the primary source that was cited.

Secondary sources are often just as valuable as primary sources, or potentially more valuable. When beginning your search, secondary sources can provide links to a wealth of primary sources that the secondary source author has already vetted for you, and likely with similar intentions. This is especially true of research handbooks. You will come across both types of literature wherever you search, and they both provide a landscape for your topic and add value to your literature review.

Regardless of being a primary or secondary source, you want to make sure the literature you review is peer-reviewed. Peer-reviewed simply means that the article was reviewed by two to three scholars in the field before it was published. Books, or edited books, would have also gone through a peer-review process. We often recommend teachers to look at professional books from reputable publishing companies and professional organizations, such as ASCD, NCTE, NCTM, or NCSS. This is a way for scholars to objectively review each other’s work to maintain a high level of quality and ethics in the publication of research. Most databases have mostly peer-reviewed journals, and often provide a filter to sort out the non-peer-reviewed journals.

Using the Internet

The internet is a valuable research tool and is becoming increasingly efficient and reliable in providing peer-reviewed literature. Sites like Google Scholar are especially useful. Often, and depending on the topic, the downside of internet-based searches is that it will generate thousands or millions of sources. This can be overwhelming, especially for new researchers, and you will have to develop ways to narrow down the results.

Professional organization websites will also have resources or links to sources that have typically been vetted. With all internet sources, you should evaluate the information for credibility and authority.

Evaluating sources from the Internet

Evaluating internet sources is a whole field of study and research within itself, and an in-depth discussion would take away from the focus of this book. However, O’ Dochartaigh (2007) provides a chapter to help guide the internet source evaluation process. Here is a brief summary, based on O’ Dochartaigh’s book, to give you a general idea of the task of evaluating sources:

• Examine if the material belongs to an advocacy group. Many times, these sources are fine, however, they require extra examination for bias or funding interests.
• As mentioned above, many academic papers are published in refereed journals which are subject to peer-review. Papers found on academic or university websites are typically refereed in some manner; however, some papers are posted by academics on their personal sites and have not been reviewed by other academics. Papers published solely by academics or other experts require further scrutiny before citing.
• When you are reviewing newspaper and magazine articles from the internet be weary of potential conflicts of interest based on the political stance of that periodical.

Therefore, it is wise to consider the objectivity of any source you find on the internet before you accept the literature.

We always recommend that students consider a few questions in their evaluation of sources, which are similar to the formal questions outlined by O’ Dochartaigh (2007):

• Is it clear who is responsible for the document?
• Is there any information about the person or organization responsible for the page?
• Is there a copyright statement?
• Does it have other publications that reinforce its authority?
• Are the sources clearly listed so they can be verified?
• Is there an editorial involvement?
• Are the spelling and grammar correct?
• Are biases and affiliations clearly stated?
• Are there dates for when the document was last updated or revised?

Organizing your Literature

When you begin, here are some things to think about as your read the literature. Again, these are not definitive, but merely provided for guidance. These questions are especially focused on other action research literature:

Questions to Think about as You Examine the Literature

• What was the context of their research?
• Who was involved? Was it a collaborative project?
• Was the choice of using action research as a method justified? Are any models discussed?
• What ‘actions’ actually took place?
• How was data gathered?
• How was data analyzed?
• Were ethical considerations addressed? How?
• What were the conclusions? Were they justified using appropriate evidence?
• Was the report accessible? Useful?
• Is it possible to replicate the study?

Regardless of the amount of literature you review, your challenge will be to organize the literature in way that is manageable and easy to reference. It is important to keep a record of what you read and how it relates conceptually to your topic. Some researchers even use the questions above to organize their literature. It is easy to read and think about the content of an article by making brief notes, however, this is often not enough to initially begin to develop your study or write about your findings. I will state the obvious here: organizing your literature search efficiently from the start is vital!

No matter how you choose to record or document the articles you read (e.g., paper, computer, photo), I would suggest thinking about the format in terms of index cards. Index cards are a very practical and simple model because the space limits you to be precise in recording vital information about each article. I typically create a document on my computer, allow each article the space of an index card, and focus on recording the following information:

• Journal/Book Chapter Title
• Main Arguments/Key findings
• Pertinent Quote(s)
• Implications
• Connective Points (how does it relate to my work and/or other articles)

I find that these aspects provide the information I need to be refreshed on the article and to be able to use it upon review.

There are also a lot of computer applications that are very useful and efficient in managing your literature. For example, Mendeley © provides comprehensive support for reviewing literature, even allowing you to store the article itself and make comments or highlights in text. There are also many citation apps that are helpful if you continue this research agenda and use roughly the same literature for each project.

Using the Literature

Think ahead to when you have collected and read a good amount of literature on your topic. You are now ready to use the literature to think about your topic, your research question, and the methods you plan to use. It might be helpful to peek ahead to Chapter 7 where I discuss writing the literature review for a report to give you an idea of the end goal. The primary purpose of engaging in a literature review is to provide knowledge to construct a framework for understanding the landscape of your topic. I often suggest for students to think of it as constructing an argument for your research decisions, or as if you are telling a story of how we got to this point in researching your topic. Either way you are situating your research in what we know and don’t know about your topic.

Naturally we tend to think about, and potentially write about, the literature in relation to the article’s author (e.g. Clark and Porath (2016) found that…). However, more commonly today in educational research you will find that literature reviews are organized by themes. It can be a little more organic to think about literature in terms of themes because they emerge or become more defined as you read. Also thinking thematically allows the articles to naturally connect and build on each other, whereas thinking in terms of authors can fragment thinking about the topic. In terms of thinking thematically, here are some guidelines:

• Identify the significant themes that have emerged organically from the literature review. These themes would be concepts or ideas that you typed or wrote down in your note-taking or management system.
• Introduce the common concepts or ideas by themes, instead of by authors’ disjointed viewpoints. Paragraphs in a thematic literature review begin like: The research on teacher self-efficacy has identified several key factors that contribute to strong self-efficacy… .
• Lastly, once you have introduced each theme and explained it, then present evidence from your readings to demonstrate the parameters of the knowledge on the theme, including areas of agreement and disagreement among researchers. Using the evidence, explain what the evidence for the theme means to your topic and any of your own relational or critical commentary.

Another way to think about structuring a literature review is a funnel model. A funnel model goes from broad topic, to sub-topics, to link to the study being undertaken. You can think of a literature review as a broad argument using mini-arguments. To use the funnel model, list your topic and the related subtopics, then design questions to answer with the literature. For example if our topic was discussion-based online learning, we might ask the following questions before reading the literature:

• Why is discussion important in learning?
• How does discussion support the development of social, cognitive, and teacher presence in an online course?
• What does research say about the use of traditional discussion boards ?
• What does the research say about asynchronous, video-based discussion ?
• How have other researchers compared written and video responses?
• How does this literature review link to my study?

O’Leary (2004) provides an interesting representation and model of the purpose for the literature review in the research process, in Figure 3.1. We will leave this for you to think about before moving on to Chapter 4.

• We will talk about this aspect of literature reviews further in Chapters 6 and 7. ↵

Action Research Copyright © by J. Spencer Clark; Suzanne Porath; Julie Thiele; and Morgan Jobe is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License , except where otherwise noted.

Share This Book

Want to create or adapt books like this? Learn more about how Pressbooks supports open publishing practices.

Step 3a: Literature Review

Module 2: Action Research Question & Literature Review

What is a Literature Review?

Generally speaking, a literature review would involve an in-depth scan of available material to identify material and gaps in your field of study.

The following videos explain the purpose and steps of a literature review in more detail.

What is a Literature Review? Explained with a REAL Example

Source: Scribbr . YouTube, 25 Mar 2020.

Additional Resources

To further your understanding, view the following video: What is a Literature Review?

The Key Benefits of a Literature Review

Completing a lit review provides numerous benefits to the researcher.

Flash Cards

Using Databases and Keyword Searches to Find Scholarly Research Literature

Keywords/Descriptors: These are specific terms related to your research topic. By searching with these keywords, you will find a list of scholarly articles where these terms appear.

Alternative Search Methods: Beyond keywords, there are other methods to explore, which can be equally effective.

To learn about conducting effective searches in scholarly databases, please review the following booklets and watch the instructional videos provided. These will guide you through the process of keyword searches and introduce other search strategies.

Interactive Book

Finding Scholarly Research Literature

Be sure to view the following booklet, which will help you to search for scholarly articles.

Action Research Handbook Copyright © by Dr. Zabedia Nazim and Dr. Sowmya Venkat-Kishore is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License , except where otherwise noted.

Share This Book

Research Process :: Step by Step

• Introduction
• Select Topic
• Identify Keywords
• Background Information
• Develop Research Questions
• Refine Topic
• Search Strategy
• Popular Databases
• Evaluate Sources
• Types of Periodicals
• Reading Scholarly Articles
• Primary & Secondary Sources
• Organize / Take Notes
• Writing & Grammar Resources
• Annotated Bibliography
• Literature Review
• Citation Styles
• Paraphrasing
• Privacy / Confidentiality
• Research Process
• Selecting Your Topic
• Identifying Keywords
• Gathering Background Info
• Evaluating Sources

Organize the literature review into sections that present themes or identify trends, including relevant theory. You are not trying to list all the material published, but to synthesize and evaluate it according to the guiding concept of your thesis or research question.  

What is a literature review?

A literature review is an account of what has been published on a topic by accredited scholars and researchers. Occasionally you will be asked to write one as a separate assignment, but more often it is part of the introduction to an essay, research report, or thesis. In writing the literature review, your purpose is to convey to your reader what knowledge and ideas have been established on a topic, and what their strengths and weaknesses are. As a piece of writing, the literature review must be defined by a guiding concept (e.g., your research objective, the problem or issue you are discussing, or your argumentative thesis). It is not just a descriptive list of the material available, or a set of summaries

A literature review must do these things:

• be organized around and related directly to the thesis or research question you are developing
• synthesize results into a summary of what is and is not known
• identify areas of controversy in the literature
• formulate questions that need further research

Ask yourself questions like these:

• What is the specific thesis, problem, or research question that my literature review helps to define?
• What type of literature review am I conducting? Am I looking at issues of theory? methodology? policy? quantitative research (e.g. on the effectiveness of a new procedure)? qualitative research (e.g., studies of loneliness among migrant workers)?
• What is the scope of my literature review? What types of publications am I using (e.g., journals, books, government documents, popular media)? What discipline am I working in (e.g., nursing psychology, sociology, medicine)?
• How good was my information seeking? Has my search been wide enough to ensure I've found all the relevant material? Has it been narrow enough to exclude irrelevant material? Is the number of sources I've used appropriate for the length of my paper?
• Have I critically analyzed the literature I use? Do I follow through a set of concepts and questions, comparing items to each other in the ways they deal with them? Instead of just listing and summarizing items, do I assess them, discussing strengths and weaknesses?
• Have I cited and discussed studies contrary to my perspective?
• Will the reader find my literature review relevant, appropriate, and useful?

Ask yourself questions like these about each book or article you include:

• Has the author formulated a problem/issue?
• Is it clearly defined? Is its significance (scope, severity, relevance) clearly established?
• Could the problem have been approached more effectively from another perspective?
• What is the author's research orientation (e.g., interpretive, critical science, combination)?
• What is the author's theoretical framework (e.g., psychological, developmental, feminist)?
• What is the relationship between the theoretical and research perspectives?
• Has the author evaluated the literature relevant to the problem/issue? Does the author include literature taking positions she or he does not agree with?
• In a research study, how good are the basic components of the study design (e.g., population, intervention, outcome)? How accurate and valid are the measurements? Is the analysis of the data accurate and relevant to the research question? Are the conclusions validly based upon the data and analysis?
• In material written for a popular readership, does the author use appeals to emotion, one-sided examples, or rhetorically-charged language and tone? Is there an objective basis to the reasoning, or is the author merely "proving" what he or she already believes?
• How does the author structure the argument? Can you "deconstruct" the flow of the argument to see whether or where it breaks down logically (e.g., in establishing cause-effect relationships)?
• In what ways does this book or article contribute to our understanding of the problem under study, and in what ways is it useful for practice? What are the strengths and limitations?
• How does this book or article relate to the specific thesis or question I am developing?

Text written by Dena Taylor, Health Sciences Writing Centre, University of Toronto

http://www.writing.utoronto.ca/advice/specific-types-of-writing/literature-review

• << Previous: Annotated Bibliography
• Next: Step 5: Cite Sources >>
• Last Updated: May 13, 2024 11:24 AM
• URL: https://libguides.uta.edu/researchprocess

University of Texas Arlington Libraries 702 Planetarium Place · Arlington, TX 76019 · 817-272-3000

• Internet Privacy
• Accessibility
• Problems with a guide? Contact Us.

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to  upgrade your browser .

Enter the email address you signed up with and we'll email you a reset link.

• We're Hiring!
• Help Center

Literature review on the use of action research in higher education

2016, Educational Action Research

Related Papers

Journal of Further and Higher Education

Educational Action Research

Lily Orland-Barak

Denise Sweeney

Psychology Learning & Teaching

Cathal O'Siochru

Psychology lecturers are well-qualified to carry out action research which would contribute to the theoretical understanding of learning as well as having practical benefits for students. Researchers are urged to collect evidence to influence policy where higher education is facing new challenges, whether from changing economic conditions, technological developments, globalisation, student diversity, or greater expectations for personalised, engaging, and flexible learning. Five specific areas within the teaching of psychology are identified as offering rich opportunities for collaborative action research: study abroad, study skills for transition to university, engaging students with statistics, gamification, and teaching psychology to students from other disciplines. Pedagogical action research demonstrates how knowledge and skills in psychology can be applied to solve practical problems, providing role models of psychological literacy to students, who can also beneficially be involved as participant researchers. Pedagogical research is particularly desirable when students are learning a new way of thinking.

Kenan DİKİLİTAŞ , Ida Bruheim Jensen

Japie Heydenrych

Pieter Du Toit

Roxanne Greenidge-Waithe

British Educational Research Journal

Juny Montoya

JALT Journal

Jerry Gebhard

In this article I describe three action research projects done by teachers at Teachers College, Columbia University, Tokyo MA TESOL Program. I discuss the benefits of doing action research (how it helps us to make more informed teaching decisions; gain skills at posing and solving teaching problems; expand reflective skills; create a forum to discuss teaching issues and beliefs), as well as its limitations (a focus only on problems; a narrowly defined linear process). I then highlight other avenues to expand awareness, such as &quot;exploring to see what happens&quot; by trying the opposite, exploring &quot;what we actually do&quot; as opposed to &quot;what we think we do,&quot; considering &quot;what we believe in relation to what we do,&quot; and exploring to &quot;gain emotional clarity.&quot; アクションリサーチを使った教育について考える-検証例、利点と限界 本論文では、コロンビア大学ティーチャーズ･カレッジ東京校英語教授法修士課程プログラムで学ぶ教師たちによって行われた３つのアクションリサーチについて語り、アクションリサーチがもたらす利点（教師自身の自律した教育的判断能力、問題提示能力、解決能力、また、反省能力が高まること。教育やその信念について話し合う場が提供さ...

RELATED PAPERS

Leidy Stefanny Gonzalez Suarez

Revista de Graduação USP

Marcos Garcia Neira

Leonardo Quintana

Parasite Epidemiology and Control

Bruno Goddeeris

food-scape.net

Joseph Levi

Shariff Lawal

Honam Mathematical Journal

Izhar Uddin (Asstt. Prof., D/o Mathematics)

The Plant Journal

Isabel Velasco Z

Pedro Ferreira

Physical Review Letters

Tenzin Wangchuk

Cancer research

Marie-Christine Bissery

Anne Parker

VNU Journal of Science: Policy and Management Studies

Dự Phòng Y Học

İSLAM İKTISADI VE FINANSI TEORIK VE AMPIRIK ÇALIŞMALAR

FATİH VOLKAN AYYILDIZ

Martin Melles

Jurnal Standardisasi

ellia kristiningrum

Occupational Stress in Ethiopian Federal Police: Validating the Organizational and Operational Police Stress Questionnaire

Tamirat Mulugeta , Tamirat Bekele , Teka Mengesha

International Journal of Image, Graphics and Signal Processing

DIPAK SITARAM MARATHE

Nuclear Instruments and Methods in Physics Research

Ryoichi Ishihara

International Journal of Molecular Sciences

Federica Sangiuolo

Miriam Sreeram

Frontiers in Surgery

Marco Ajello

Anton Schleiss

Experimental Cell Research

Maria Letizia Focarete

anu dubai2024

RELATED TOPICS

•   We're Hiring!
•   Help Center
• Find new research papers in:
• Health Sciences
• Earth Sciences
• Cognitive Science
• Mathematics
• Computer Science
• Academia ©2024

Differences in quality of anticoagulation care delivery according to ethnoracial group in the United States: A scoping review

• Open access
• Published: 11 May 2024

Cite this article

You have full access to this open access article

• Sara R. Vazquez   ORCID: orcid.org/0000-0002-9267-8980 1 ,
• Naomi Y. Yates 2 ,
• Craig J. Beavers 3 , 4 ,
• Darren M. Triller 3 &
• Mary M. McFarland 5  

64 Accesses

2 Altmetric

Explore all metrics

Anticoagulation therapy is standard for conditions like atrial fibrillation, venous thromboembolism, and valvular heart disease, yet it is unclear if there are ethnoracial disparities in its quality and delivery in the United States. For this scoping review, electronic databases were searched for publications between January 1, 2011 – March 30, 2022. Eligible studies included all study designs, any setting within the United States, patients prescribed anticoagulation for any indication, outcomes reported for ≥ 2 distinct ethnoracial groups. The following four research questions were explored: Do ethnoracial differences exist in 1) access to guideline-based anticoagulation therapy, 2) quality of anticoagulation therapy management, 3) clinical outcomes related to anticoagulation care, 4) humanistic/educational outcomes related to anticoagulation therapy. A total of 5374 studies were screened, 570 studies received full-text review, and 96 studies were analyzed. The largest mapped focus was patients’ access to guideline-based anticoagulation therapy (88/96 articles, 91.7%). Seventy-eight articles made statistical outcomes comparisons among ethnoracial groups. Across all four research questions, 79 articles demonstrated favorable outcomes for White patients compared to non-White patients, 38 articles showed no difference between White and non-White groups, and 8 favored non-White groups (the total exceeds the 78 articles with statistical outcomes as many articles reported multiple outcomes). Disparities disadvantaging non-White patients were most pronounced in access to guideline-based anticoagulation therapy (43/66 articles analyzed) and quality of anticoagulation management (19/21 articles analyzed). Although treatment guidelines do not differentiate anticoagulant therapy by ethnoracial group, this scoping review found consistently favorable outcomes for White patients over non-White patients in the domains of access to anticoagulation therapy for guideline-based indications and quality of anticoagulation therapy management. No differences among groups were noted in clinical outcomes, and very few studies assessed humanistic or educational outcomes.

Graphical Abstract

Scoping Review: Differences in quality of United States anticoagulation care delivery by ethnoracial group. AF = atrial fibrillation; AMS = anticoagulation management service; DOACs = direct oral anticoagulants; INR = international normalized ratio; PSM = patient self-management; PST = patient self-testing

Avoid common mistakes on your manuscript.

Introduction

It is well-established that in the United States (US) ethnoracial disparities exist in various aspects of health care. Specifically, persons identifying with an ethnoracial minority group may have more challenging access to health care, worse clinical outcomes, and higher dissatisfaction with care compared to White persons [ 1 , 2 , 3 , 4 , 5 ]. There are differences by ethnoracial group in the prevalence of the three most common indications for which anticoagulants are prescribed, stroke prevention in atrial fibrillation (AF), treatment of venous thromboembolism (VTE), and valvular heart disease [ 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 ]. Specifically, VTE is most prevalent in Black patients compared to White and Asian patients, whereas AF is most prevalent in White patients compared to Black, Asian, and Hispanic patients [ 9 , 10 , 15 ]. Calcific heart valve disease has the most relevance to the US population, and epidemiologic data has shown that aortic stenosis is more prevalent in White patients compared to Black, Asian, and Hispanic patients [ 17 ]. Despite these epidemiologic differences, there is no evidence to suggest there should be any difference in treatment strategies across ethnoracial patient groups.

While studies have demonstrated genotypic differences that may result in different warfarin dose requirements[ 18 ], and early studies may indicate genotypic differences in direct oral anticoagulant (DOAC) response [ 19 ], no US-based labeling or guidelines recommend a difference in prescription or delivery of anticoagulation care based on race or ethnicity. However, it is unclear if there are in fact differences in the type and quality of anticoagulation therapy, which is standard of care for each of these conditions [ 20 , 21 , 22 , 23 , 24 ]. Anticoagulants remain in the top three classes of drugs causing adverse drug events (primarily bleeding) in the United States, according to the 2014 National Action Plan for Adverse Drug Event Prevention. One of the goals of the National Action Plan was to identify patient populations at higher risk for these adverse drug events to inform the development of targeted harm reduction strategies [ 25 ]. If ethnoracial minority patients are receiving sub-optimal anticoagulation therapy in certain measurable areas of anticoagulation quality, it is vital to highlight the areas of disparity so that these can be explored and care optimized. Anticoagulation providers often have high frequency contact with their patients and can be a reliable connection between disproportionately affected patients and a system in need of change. Systematic reviews of ethnoracial disparities in AF and VTE have been conducted. The AF review assessed AF prevalence among racial groups as well as differences in symptoms and management, including stroke prevention with warfarin or DOACs [ 9 ]. The VTE review specifically assessed VTE prevalence and racial differences in COVID-19 and did report the use of any prophylactic anticoagulation, but this was not part of the analysis [ 26 ]. No review of racial disparities in quality of anticoagulation therapy was found in search results conducted prior to protocol.

In this study we aimed to identify any potential ethnoracial disparities in anticoagulation care quality in the US. The decision to limit the study to a US population was based on our observation that the US has a unique history of interactions between racial and ethnic groups that may not necessarily be reflected by studies conducted in other countries. Additionally, health care delivery systems vary widely across the world, and we wanted to include the data most relevant to the potential racial disparities existing in the US health care system. The term “race” was used to identify a group of people with shared physical characteristics believed to be of common ancestry whereas the term “ethnicity” refers to a group of people with shared cultural traditions [ 27 ]. We recognize these terms may be far more complex. In order to encompass both the physical and cultural aspects of a patient’s identity we have chosen to use the term “ethnoracial” for this study [ 27 ]. Highlighting existing differences will serve as a stimulus for institutions and clinicians to assess current services, implement quality improvement measures, and inform future research efforts to deliver optimal anticoagulation care for all patients. The scoping review protocol was registered December 22, 2021 to Open Science Framework, https://doi.org/10.17605/OSF.IO/9SE7H [ 28 ].

We conducted this scoping review with guidance from the 2020 version of the JBI Manual for Evidence Synthesis and organized to Arksey's five stages: 1) identifying the research question, 2) identifying relevant studies, 3) study selection, 4) charting the data and 5) collating, summarizing and reporting the results [ 29 , 30 ]. For transparency and reproducibility, we followed the PRISMA-ScR and PRISMA-S reporting guidelines in reporting our results [ 31 ]. We used Covidence (Veritas Health Innovation,) an online systematic reviewing platform to screen and select studies. Citation management and duplicate detection and removal was accomplished with EndNote, version 19 (Clarivate Analytics.) Data was charted from our selected studies using REDCap, an electronic data capture tool hosted at the University of Utah [ 32 ].

Literature searching

An information specialist developed and translated search strategies for the online databases using a combination of keywords and controlled subject headings unique to each database along with team feedback. Peer review of the strategies was conducted by library colleagues using the PRESS guidelines. [ 33 ] Electronic databases searched included Medline (Ovid) 2011–2022, Embase (embase.com) 2011–2022, CINAHL Complete (Ebscohost) 2011–2022, Sociological Abstracts (ProQuest) 2011–2022, International Pharmaceutical Abstracts (Ovid) 2011–2022, Scopus (scopus.org) 2011–2022 and Web of Science Core Collection (Clarivate Analytics) 2011–2022. Limits included a date range from January 1, 2011 to March 30—April 19, 2022, as not all database results were exported on the same day. See Supplemental File 1 for detailed search strategies. A search of grey literature was not conducted due to time and resource constraints.

Study Selection

For inclusion, each study required two votes by independent reviewers for screening of titles and abstracts followed by full-text review. A third reviewer provided the deciding vote. Data extraction was performed by two independent reviewers, and consensus on any discrepancies was reached via discussion between the reviewers. The data form was piloted by two team members using sentinel articles prior to data extraction.

Eligible studies included all types of study designs in any setting with a population of patients of any age or gender located within the US who were prescribed anticoagulant therapy for any indication, published between January 1, 2011 – March 30, 2022 in order to capture contemporary and clinically relevant practices.

We defined the following research questions for this scoping review as described in Table  1 .

Studies must have reported any of these anticoagulation care delivery outcomes for at least 2 distinct racial or ethnic groups. We excluded genotyping studies and non-English language articles at full text review, as we had no funding for translation services. In checking references of included studies, no additional studies met inclusion criteria. In accordance with scoping review methodology, no quality assessment of included studies was conducted as our goal was to rapidly map the literature. As this is a scoping review of the literature, no aggregate or pooled analysis was performed; however, for ease of interpretation, when assessing for the directionality of the outcomes in the various studies, we categorized studies into Favoring White Group, Favoring Non-White Group, and No Differences Among Ethnoracial Groups. If studies had mixed outcomes of favoring one group for one outcome and no difference for another, then the study was categorized with the favoring group.

A PRISMA flow diagram in Fig.  1 depicts search results, exclusions, and inclusions. The search strategies retrieved 6900 results with 1526 duplicates removed. Following title and abstract screening of 5374 references, 570 articles received full-text review. The most common reason for the exclusion of 474 studies was that outcomes were not reported for two distinct ethnoracial groups (171 studies). Ninety-six studies underwent data extraction.

PRISMA Flow Diagram

Study characteristics-overall

Fifty of the 96 studies were published between 2011 and 2018 (an average of 6.25 articles per year that compared outcomes between two ethnoracial groups) and 43 of 96 studies were published in the years 2019–2021 (average 14.3 articles per year; 2022 excluded here because only 4 months of data was captured) (Fig.  2 ). Most studies analyzed an outpatient population (65.6%) for an indication of stroke prevention in AF (67.7%) in patients taking warfarin (71.9%) or DOACs (49.0%). Study population size was heterogenous, ranging from a study size of 24 patients to over 1.3 million patients (median 5,238 patients) in the 69 studies that reported population size by racial group. When stratified by size, 60.9% of the articles in the scoping review (42 articles) represented < 10,000 patients (Table  2 ).

Number of Articles by Publication Year. *2022 excluded from this figure since the search period did not capture the entire year

Study characteristics-by ethnoracial group

There were 50 studies (52.1%) where race or ethnicity was either mentioned in the title or objective of the article, with 24 of these published over the 7-year period 2011–2018 and 26 published over the 3-year period 2019 to first quarter 2022. The method for reporting race or ethnicity was unclear or unspecified in most studies (77.1%) and 16 articles (16.7%) utilized self-reporting of race or ethnicity. Most studies analyzed White or Caucasian racial groups (94.8%), followed by Black or African-American (80.2%), and many studies grouped all other racial groups into an “Other” category (41.7%) (Fig.  3 ).

Number of Articles by Ethnoracial Groups. *For study inclusion, a study had to compare outcomes for least two distinct ethnoracial groups 

White patients accounted for a median 77% of study populations, Black patients 9.5%, Hispanic/Latino patients 6.2%, “Other” racial groups 5.3%, and Asian patients 2.5%.

Study outcomes-overall

Of the 4 research questions, most studies included in this review analyzed patients’ access to guideline-based anticoagulation therapy (88/96 articles, 91.7%), clinical outcomes (42/96 articles, 43.8%), or quality of anticoagulation management (24/96 articles, 25.0%), while very few addressed humanistic or educational outcomes (5/96 articles, 5.2%) (Fig.  4 ). Many studies addressed multiple outcomes within the single study.

Number of Articles Mapped by Research Question

Seventy-eight of the 96 included studies provided statistical comparisons between ethnoracial groups, and these data are presented below.

Outcomes for research question 1: Do ethnoracial differences exist in access to guideline-based anticoagulation therapy?

Anticoagulation for a guideline-based indication.

This question focused on patients who had an indication for anticoagulation actually receiving an anticoagulant, specifically AF and VTE prophylaxis (based on risk stratification) and acute VTE. The majority of the AF studies (25/34 studies) demonstrated White patients receiving anticoagulation at significantly higher rates compared to non-White patients [ 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 ], while the six VTE studies largely demonstrated no difference among ethnoracial groups [ 61 , 62 , 63 , 64 , 65 , 66 ].

DOACs as first-line therapy for AF or VTE

Eighteen individual studies statistically assessed the outcome of DOAC as first-line therapy (compared to warfarin) for AF (15 studies), VTE treatment (2 studies), or both indications (1 study). Twelve of the 15 AF studies showed a significantly higher proportion of White patients received DOACs as first-line therapy compared to non-White patients [ 36 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 54 , 55 , 67 , 68 ]. Of those 12, 9 specifically compared White patients to Black patients. Both VTE treatment studies and the study that assessed both AF and VTE indications showed significantly higher DOAC prescribing rates for White patients compared to Black patients [ 69 , 70 , 71 ].

Anticoagulant therapy adherence/persistence

The eight studies that addressed anticoagulation therapy adherence/persistence showed variability in outcome directionality by ethnoracial group: 5 no difference [ 41 , 72 , 73 , 74 , 75 ], 2 showed better treatment adherence/persistence for White patients compared to Black patients[ 76 ] or non-White patients [ 77 ], and one showed better treatment adherence/persistence for White patients compared to Hispanic patients, but no difference in White versus Black patients [ 78 ].

Figure  5 summarizes the outcome directionality for Research Question 1 regarding access to guideline-based anticoagulation therapy. Overall, the areas of disparity identified included anticoagulation for atrial fibrillation and preferential use of DOAC therapy for AF and VTE treatment.

Outcome Directionality for the 4 Research Questions and their Subcategories. AC = anticoagulant; AMS = anticoagulation management service; INR = international normalized ratio; PST = patient self-testing; PSM = patient self-management

Research question 2: Do ethnoracial differences exist in the quality of anticoagulation therapy management?

A total of 21 studies assessed quality of anticoagulation therapy management: Warfarin time in therapeutic range (TTR)/INR (International Normalized Ratio) control 12 studies, appropriate anticoagulant dosing 3 studies, enrollment in an anticoagulation management service 5 studies, and PST/PSM one study.

In statistical comparisons of INR control in warfarin patients, all 12 studies (7 assessed mean or median TTR, 5 assessed other measures of INR control such as days spent above/below range, gaps in INR monitoring) showed White patients had favorable INR control compared to non-White patients (most comparisons included Black patients) [ 41 , 75 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 ]. Enrollment in an anticoagulation management service was statistically compared among ethnoracial groups in 5 studies, and this opportunity favored White patients compared to other racial groups in four of the five [ 41 , 82 , 86 , 88 ]. Two of the three studies that statistically analyzed appropriate anticoagulant dosing showed a higher rate of appropriate DOAC dosing in White patients compared to non-White patients [ 41 , 89 ], and the third showed no difference among ethnoracial groups for enoxaparin dosing in the emergency department [ 90 ]. The one study assessing access to PST/PSM showed that more White patients used PST compared to Black or Hispanic patients[ 91 ] (Fig.  5 ).

Research question 3: Do ethnoracial differences exist in the clinical outcomes related to anticoagulation care?

Articles assessing clinical outcomes among ethnoracial groups primarily assessed bleeding (15 articles) or thrombosis (9 articles) outcomes, and 8 articles assessing anticoagulation related hospitalization or mortality. One article addressed a net clinical outcome including major bleeding, stroke or systemic embolism, and death from any cause. This was included in the bleeding outcomes category so that it was not double-counted in the other two outcome categories. Additional details about the 24 unique studies that statistically assessed clinical outcomes including the study design, population size, ethnoracial groups studied, anticoagulants used, and statistical outcomes measured can be found in Supplementary Tables 1 and 2 .

Sixteen studies statistically assessed bleeding outcomes of varying definitions (major bleeding 13 studies, clinically relevant non-major bleeding 3 studies, any bleeding 3 studies, bleeding otherwise defined 3 studies). Six studies demonstrated no difference in bleeding outcomes by ethnoracial group [ 55 , 92 , 93 , 94 , 95 , 96 ]9 reported that White patients had lower rates of bleeding compared to Black or Asian patients,[ 53 , 80 , 83 , 85 , 97 , 98 , 99 , 100 , 101 ]. In the remaining study, Asian patients had a more favorable net clinical outcome compared to non-Asian patients [ 102 ].

Nine studies statistically assessed thrombosis outcomes among ethnoracial groups, including stroke/systemic embolism (5 studies), recurrent VTE (3 studies), or any thrombosis (1 study). The stroke outcomes by racial group were heterogeneous, with 3 studies showing better outcomes for White patients compared to Black patients[ 103 , 104 , 105 ] and two studies showing no difference in outcomes when White patients were compared to Non-White patients [ 55 , 95 ]. In three of the four VTE studies there were no differences in outcomes by ethnoracial group [ 61 , 93 , 96 ], and in one study White patients had more favorable outcomes compared to Black patients [ 106 ].

Nine studies assessed anticoagulation-related hospitalizations or mortality by ethnoracial group. Outcomes were mixed, as four studies showed no difference in hospitalizations or mortality among ethnoracial groups,[ 89 , 95 , 96 , 107 ], three studies showed White patients had a lower rate of hospitalizations[ 85 , 105 ] or mortality[ 104 , 105 ] Another study showed lower rate of mortality or hospice after intracranial hemorrhage in Black and Other race patients [ 108 ].(Fig.  5 ).

Research question 4: Do ethnoracial differences exist in the humanistic/educational outcomes related to anticoagulation therapy?

The five studies reporting this category of outcomes were heterogeneous. Of the two studies assessing anticoagulation knowledge, one showed no difference by ethnoracial group [ 109 ], and the other favored the non-White group in appropriately estimating bleeding risk [ 110 ]. One study assessed an atrial fibrillation quality of life score at 2-year follow-up after AF diagnosis and found the outcomes favored White patients [ 79 ]. Another study assessed satisfaction with VTE care and found no difference among ethnoracial groups [ 111 ]. A third study found no difference in the percentage of racial groups having a cost conversation when initiating DOAC therapy (78% Whites, 72.2% non-Whites)[ 112 ] (Fig.  5 ).

Overall outcome directionality for all four research questions is shown in Fig.  6 . A total of 79 articles demonstrated favorable outcomes for White patients compared to non-White patients, 38 articles showed no difference between White and non-White groups, and 8 articles had outcomes favoring non-White groups (the total exceeds the 78 articles with statistical outcomes as many articles reported multiple outcomes). The biggest areas of disparity between White and non-White groups are access to guideline-based anticoagulation therapy and quality of anticoagulation therapy management. Clinical outcomes relating to anticoagulation care had the least difference among ethnoracial groups. Relatively few studies assessed potential ethnoracial disparities in humanistic and educational outcomes.

Outcome Directionality for All 4 Research Questions

This scoping review assessing ethnoracial differences in the quality of anticoagulation care and its delivery to patients in the United States encompassed eleven full years of literature and resulted in the inclusion of 96 studies, 78 of which contained statistical outcomes comparisons among ethnoracial groups. The most common reason for study exclusion was that outcomes were not reported for at least two distinct ethnoracial groups. We observed that beginning in 2019 and following the racial unrest of 2020, the density of articles addressing ethnoracial disparities in anticoagulation care more than doubled. During the entire study period, half of studies had race or ethnicity as the focus or objective of the paper, but this was largely driven by articles published after 2019.

Only 16% of included articles documented self-reporting of racial identity, with most of the remainder using an unspecified method for documenting racial identity. It is likely that many studies utilize demographic information extracted from an electronic medical record (EMR), but it is often unclear if that is truly self-reported race. A second element this scoping review identified was that many studies analyzed two or three ethnoracial groups and then categorized all others into a heterogenous “Other” category. For example, frequently studies would categorize patients as White, Black, and “Other.” It is unclear whether those in a racial category labeled as “Other” had an unknown or missing racial identity in the EMR, or intentionally chose not to disclose. It is also likely that study investigators decided to classify ethnoracial groups with lower population sizes into a miscellaneous category. There were few studies (15%) that specifically assessed patients identifying as Native American/Alaska Native, Native Hawaiian/Pacific Islander, and multiracial. While Hispanic/Latino is an ethnicity, most studies categorized it as a separate “race” category. Of the 37 studies that analyzed “Asian” patient populations, none specifically defined “Asian” beyond that. The US Census Bureau defines “Asian” race as a person having origins of the Far East, Southeast Asia, or the Indian subcontinent [ 113 ]. This broad definition encompasses many different ethnicities which could represent variability in health outcomes if better defined and more frequently analyzed. These may be opportunities for EMR systems to improve transparency for how race, ethnicity, and language preference are captured and for those designing research studies to be thoughtful and intentional about analyzing the ethnoracial identities of the study population, perhaps in alignment with the minimum 5 racial categories utilized by the US Census Bureau, the National Institutes of Health, and the Office of Management and Budget (White, Black, American Indian/Alaska Native, Asian, Native Hawaiian/Pacific Islander, with permission for a “some other race” category and the option to select multiple races) [ 113 ]. Since 2017 Clinicaltrials.gov has required the reporting of race/ethnicity if collected, and there is good compliance with this requirement, but less so in publication of the work [ 114 ].

We examined the proportion of ethnoracial groups represented for each of the disease states in the studies included in this scoping review, relative to disease state prevalence and found a discrepancy. For AF, prevalence in White patients was 11.3%, in Black patients 6.6%, and in Hispanic patients 7.8% [ 15 ]. However, the representation in AF studies in this review were 74% White, 13% Black, and 8% Hispanic. Assessing VTE incidence by race is more difficult, as studies have shown regional and time variation, with Black patients typically having a higher incidence compared to other ethnoracial groups [ 16 ]. In this review, however, of the studies assessing VTE treatment or prophylaxis, only 16% of the patient population identified as Black, whereas 70% identified as White. There were only 3 studies that assessed a valvular heart disease population, making ethnoracial group representation difficult to assess.

The majority of studies captured in this review analyzed patients in the outpatient setting, for the anticoagulation indication of stroke prevention in AF, taking either warfarin or DOAC. Few studies involved the acute care setting or injectable anticoagulants, representing an area for future study of potential ethnoracial disparities.

Overall, the majority of studies in this scoping review addressed ethnoracial disparities in patients’ access to guideline-based anticoagulation therapy, clinical outcomes related to anticoagulation care, and quality of anticoagulation management. A research gap identified was more study is needed to assess gaps in educational outcomes such as anticoagulation and disease state knowledge, shared decision-making willingness and capability, and humanistic outcomes such as quality of life or satisfaction with anticoagulation therapy.

In analyzing the first research question regarding ethnoracial differences in access to guideline-based anticoagulation therapy, the majority of studies addressed use of any anticoagulation for stroke prevention in AF in patients above a threshold risk score and the preferential use of DOACs as first-line therapy instead of warfarin for AF. In both categories, patients in a non-White ethnoracial group (particularly Black patients) received recommended therapy less often than patients identified as White. It is unclear why this is the case. It could be on the patient, provider, and/or system level. It is possible that some studies more successfully adjusted for covariates than others. Sites or settings with systematic processes like order sets or clinical decision support systems in place for standard prescribing may be more successful in equitably prescribing indicated therapies. In one large study in the Veterans Affairs population of AF patients, even after adjusting for numerous variables that included clinical, demographic, socioeconomic, prescriber, and geographic site factors, DOAC prescribing remained lower in Asian and Black patients when compared with White patients. The authors in that study postulate that non-White populations may be less receptive to novel therapies due to historical mistrust of the health care system or have reduced access to education about the latest treatments, and they give the example of direct-to-consumer advertising [ 42 ]. It has also previously been demonstrated that prescribing of oral anticoagulation and particularly DOACs is lower in non-White patients [ 41 ]. These are difficult to capture as standard covariates, which is why further study is needed. We examined the publication dates for both access categories to see if perhaps there was a lack of contemporary data skewing the outcomes. However, for both anticoagulation for a guideline-based indication and DOACs as first-line therapy, the majority of articles came from the time period 2019–2021 (24 of 40 articles, and 15 of 18 articles, respectively), well after guideline updates preferentially recommended DOACs [ 34 , 35 ]. Also, there were relatively few studies addressing guideline-based therapy for VTE treatment and prophylaxis, making assessment of disparities difficult. Regarding access, it is well established that race and ethnicity often determine a patient’s socioeconomic status and that low socioeconomic status and its correlates (e.g., reduced education, income, and healthcare access) are associated with poorer health outcomes [ 115 ]. However, at each level of income or education, Black patients experience worse health outcomes than Whites [ 116 ]. So, low socioeconomic status does not fully explain poorer health outcomes for non-White individuals.

After examining access to appropriate and preferred anticoagulation therapy, the second research question of this scoping review examined potential ethnoracial disparities in the quality of anticoagulation therapy management. INR control measures such as time in therapeutic INR range are a surrogate measure of both thrombotic and bleeding outcomes and frequently used as a way to assess quality of warfarin therapy. The studies identified in this review showed clear disparity between White and non-White patient groups (especially Black patients), however all twelve studies comparing TTR among ethnoracial groups were published prior to 2019. This could be due to the decline in warfarin prescribing relative to increases in DOAC prescribing [ 117 , 118 , 119 ], but there remain patient populations that require or choose warfarin, so this marker of anticoagulation control remains relevant and requires continued reassessment. There were relatively few studies assessing other markers of anticoagulation management quality such as anticoagulation management service enrollment, appropriate DOAC dosing, and access to quality improvement strategies like PST or PSM. Few studies assessed educational outcomes, yet this may have relevance to the above anticoagulation care quality question. For those patients who remain on warfarin, dietary Vitamin K consistency is an example of a key educational point that links directly to INR control. It is unclear if there are disparities in this type of education among ethnoracial groups that may have more far-reaching effects.

Of note, clinical outcomes related to anticoagulant therapy seemed to have the fewest areas of disparity, although the number of articles was small. This suggests that if patients have access to high quality anticoagulation therapy, there is a promising sign that optimal clinical outcomes can be achieved for all ethnoracial groups.

There are some limitations of this scoping review that warrant consideration. First, we chose fairly broad inclusion criteria (all anticoagulants, all study types) because a review of this type had never been performed before. This resulted in a relatively large number of included articles for a scoping review. Second, there is likely a high degree of heterogeneity among patient populations and outcomes definitions. However, as this is a scoping review with the goal to present an overview of the literature and not report on composite outcomes, a risk of bias assessment was not performed. Third is our decision to group patients into White and non-White groups for assessment of outcome directionality. In doing so, we may have missed subtle differences in outcomes between various non-White ethnoracial groups. Fourth, in our main search we included all studies that reported outcomes, but due to scope, we only reported outcome directionality for studies that statistically compared outcomes between ethnoracial groups. Finally, due to the large number of studies that required review and analysis, this was a lengthy undertaking and we are certain that additional studies have been published since the closure of our search period.

In line with the 2014 National Action Plan for Adverse Drug Event Prevention’s goal of identifying patient populations at higher risk of adverse drug events, this scoping review highlights several areas where quality of anticoagulation care can be optimized for all patients. Future research opportunities in ethnoracial differences in the quality of anticoagulation care are summarized in Table  3 . While the scoping review focused exclusively on the evaluation of peer-reviewed manuscripts, the heterogeneity of terminology and methodologies identified in the published papers may have implications for national health policy relating to the quality and safety of care (e.g.the Medicare Quality Payment Program) [ 120 ]. To accurately and reliably quantify important disparities in AC-related care and support effective improvement initiatives, attention and effort will need to be invested across the full continuum of quality measure development [ 121 ], measure endorsement [ 122 ], measure selection, and status assignment within value-based payment programs (e.g., required/optional, measure weighting) [ 123 ]. The findings of the scoping review may be of utility to such efforts, and the development and implementation of suitable quality measures will likely be of value to future research efforts in this important therapeutic area.

Conclusions

Treatment guidelines do not recommend differentiating anticoagulant therapy by ethnoracial group, yet this scoping review of the literature demonstrates consistent directionality in favor of White patients over non-White patients in the domains of access to anticoagulation therapy for guideline-based indications, prescription of preferred anticoagulation therapies, and quality of anticoagulation therapy management. These data should serve as a stimulus for an assessment of current services, implementation of quality improvement measures, and inform future research to make anticoagulation care quality more equitable.

Data Availability

Data are available on request from the corresponding author.

Wheeler SM, Bryant AS (2017) Racial and Ethnic Disparities in Health and Health Care. Obstet Gynecol Clin North Am 44(1):1–11

Article   PubMed   Google Scholar  

Manuel JI (2018) Racial/Ethnic and Gender Disparities in Health Care Use and Access. Health Serv Res 53(3):1407–1429

Nadeem MF, Kaiser LR (2022) Disparities in Health Care Delivery Systems. Thorac Surg Clin 32(1):13–21

Wallace J et al (2021) Changes in Racial and Ethnic Disparities in Access to Care and Health Among US Adults at Age 65 Years. JAMA Intern Med 181(9):1207–1215

Article   PubMed   PubMed Central   Google Scholar  

Churchwell K et al (2020) Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association. Circulation 142(24):e454–e468

Gomez SE et al (2023) Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control. J Interv Card Electrophysiol 66(5):1279–1290

Tamirisa KP et al (2021) Racial and Ethnic Differences in the Management of Atrial Fibrillation. CJC Open 3(12 Suppl):S137–S148

Eberly LA et al (2021) Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation. JAMA Netw Open 4(2):e210247

Ugowe FE, Jackson LR, Thomas KL (2018) Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review. Heart Rhythm 15(9):1337–1345

Xu Y, Siegal DM, Anand SS (2021) Ethnoracial variations in venous thrombosis: Implications for management, and a call to action. J Thromb Haemost 19(1):30–40

Erinne I et al (2021) Racial disparities in the treatment of aortic stenosis: Has transcatheter aortic valve replacement bridged the gap? Catheter Cardiovasc Interv 98(1):148–156

Ali A et al (2022) Racial and Ethnic Disparities in the Use of Transcatheter Aortic Valve Replacement in the State of Connecticut. Cardiovasc Revasc Med 37:7–12

Pienta MJ et al (2023) Racial disparities in mitral valve surgery: A statewide analysis. J Thorac Cardiovasc Surg 165(5):1815-1823.e8

Alkhouli M et al (2019) Racial Disparities in the Utilization and Outcomes of Structural Heart Disease Interventions in the United States. J Am Heart Assoc 8(15):e012125

Heckbert SR et al (2020) Differences by Race/Ethnicity in the Prevalence of Clinically Detected and Monitor-Detected Atrial Fibrillation: MESA. Circ Arrhythm Electrophysiol 13(1):e007698

Zakai NA et al (2014) Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation 129(14):1502–1509

Lamprea-Montealegre JA et al (2021) Valvular Heart Disease in Relation to Race and Ethnicity: JACC Focus Seminar 4/9. J Am Coll Cardiol 78(24):2493–2504

Tamargo J et al (2022) Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events. Eur Heart J Cardiovasc Pharmacother 8(7):738–751

Kanuri SH, Kreutz RP (2019) Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants. J Pers Med 9(1):7

Craig TJ, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland CJ Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie LK, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW (2019) Circulation 140 (2):e125–e151. https://doi.org/10.1161/CIR.000000000000066

Ortel TL et al (2020) American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 4(19):4693–4738

Article   CAS   PubMed   PubMed Central   Google Scholar  

Stevens SM et al (2021) Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest 160(6):e545–e608

Article   CAS   PubMed   Google Scholar  

Schünemann HJ et al (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv 2(22):3198–3225

Otto CM et al (2021) 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143(5):e72–e227

PubMed   Google Scholar  

National Action Plan for Adverse Drug Event Prevention (2014) Office of Disease Prevention and Health Promotion. US Department of Health and Human Services, Washington, DC

Google Scholar  

Bhakta S et al (2022) A systematic review and meta-analysis of racial disparities in deep vein thrombosis and pulmonary embolism events in patients hospitalized with coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord 10(4):939-944.e3

Corbie-Smith G et al (2008) Conceptualizing race in research. J Natl Med Assoc 100(10):1235–1243

Vazquez SR, Yates NYY, McFarland MM (2022). Differences in anticoagulant care delivery according to ethnoracial group in the United States: a scoping review protocol. Open Sci Fram osf.io/eydsa. https://doi.org/10.17605/OSF.IO/9SE7H

Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H (2020) Joanna briggs institute reviewer's manual. Aromataris E, Munn Z (eds). Publisher: Joanna briggs institute. Chapter: chapter 11: scoping reviews

Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8(1):19–32

Article   Google Scholar  

Rethlefsen ML et al (2021) PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev 10(1):39

Harris PA et al (2009) Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381

McGowan J et al (2016) PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol 75:40–46

Kearon C et al (2016) Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 149(2):315–352

Lip GYH et al (2018) Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report. Chest 154(5):1121–1201

al Taii, H. and S. Al-Kindi, Racial disparities in prescriptions of oral anticoagulants among patients with atrial fibrillation., in 24th International Atrial Fibrillation Symposium (2019) Boston. MA, USA

Bhave PD et al (2015) Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm 12(7):1406–1412

Chapman SA et al (2017) Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS. BMC Health Serv Res 17(1):127

Chen Q et al (2021) Prevalence and the factors associated with oral anticoagulant use among nursing home residents. J Clin Pharm Ther 46(6):1714–1728

Deitelzweig S et al (2020) Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA. J Med Econ 23(12):1389–1400

Essien UR et al (2018) Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II. JAMA Cardiol 3(12):1174–1182

Essien UR et al (2021) Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System. JAMA Netw Open 4(7):e2114234

Essien UR, Kim N, Hausmann LR, Mor MK, Good C, Gellad WF, Fine MJ (2020) Abstract: racial and ethnic disparities in anticoagulant choice for atrial fibrillation in the veterans health administration: results from the reach-af study. J Gen Int Med J 35(1):S250–251

Essien UR et al (2022) Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities. Circ Cardiovasc Qual Outcomes 15(2):e008389

Essien UR et al (2020) Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data. J Natl Med Assoc 112(1):103–108

Fohtung RB, Novak E, Rich MW (2017) Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults. J Am Geriatr Soc 65(11):2405–2412

Lewis WR et al (2011) Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke. Am Heart J 162(4):692-699.e2

Martin Diaz C et al (2021) Anticoagulation After Ischemic Stroke or Transient Ischemic Attack (TIA) in the Time of Direct Oral Anticoagulation (DOAC) and Thrombectomy. Cureus 13(8):e17392

PubMed   PubMed Central   Google Scholar  

Mentias A et al (2021) Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter. J Am Heart Assoc 10(17):e021674

Obi CA et al (2022) Examination of anticoagulation prescription among elderly patients with atrial fibrillation after in-hospital fall. J Thromb Thrombolysis 53(3):683–689

Piccini JP et al (2019) Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable. Circulation 139(12):1497–1506

Raji MA et al (2013) National utilization patterns of warfarin use in older patients with atrial fibrillation: a population-based study of Medicare Part D beneficiaries. Ann Pharmacother 47(1):35–42

Schwartz SM et al (2019) Discriminative Ability of CHA. Am J Cardiol 123(12):1949–1954

Shahid I et al (2021) Meta-Analysis of Racial Disparity in Utilization of Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation. Am J Cardiol 153:147–149

Tedla YG et al (2020) Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients. J Stroke Cerebrovasc Dis 29(5):104718

Thomas KL et al (2013) Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure. J Am Heart Assoc 2(5):e000200

Waddy SP et al (2020) Racial/Ethnic Disparities in Atrial Fibrillation Treatment and Outcomes among Dialysis Patients in the United States. J Am Soc Nephrol 31(3):637–649

Wetmore JB et al (2019) Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis. Am J Cardiol 123(4):598–604

Winkelmayer WC et al (2012) Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol 25(3):341–353

Zahuranec DB et al (2017) Stroke Quality Measures in Mexican Americans and Non-Hispanic Whites. J Health Dispar Res Pract 10(1):111–123

Addo-Tabiri NO et al (2020) Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism. Am J Clin Oncol 43(2):94–100

Freeman AH et al (2016) Venous thromboembolism following minimally invasive surgery among women with endometrial cancer. Gynecol Oncol 142(2):267–272

Friedman AM et al (2013) Underuse of postcesarean thromboembolism prophylaxis. Obstet Gynecol 122(6):1197–1204

Lau BD et al (2015) Eliminating Health Care Disparities With Mandatory Clinical Decision Support: The Venous Thromboembolism (VTE) Example. Med Care 53(1):18–24

Owodunni OP et al (2020) Using electronic health record system triggers to target delivery of a patient-centered intervention to improve venous thromboembolism prevention for hospitalized patients: Is there a differential effect by race? PLoS ONE 15(1):e0227339

Shah S et al (2021) Implementation of an Anticoagulation Practice Guideline for COVID-19 via a Clinical Decision Support System in a Large Academic Health System and Its Evaluation: Observational Study. JMIR Med Inform 9(11):e30743

Steinberg BA et al (2013) Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation. J Am Heart Assoc 2(6):e000535

Vaughan Sarrazin MS et al (2014) Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran. Am J Med 127(12):1179–1185

Nathan AS et al (2019) Racial, Ethnic, and Socioeconomic Inequities in the Prescription of Direct Oral Anticoagulants in Patients With Venous Thromboembolism in the United States. Circ Cardiovasc Qual Outcomes 12(4):e005600

Singh BP, Sitlinger A, Saber I, Thames E, Beckman M, Reyes N, Schulteis RD, Ortel T (2016) Direct oral anticoagulant usage in the treatment of venous thromboembolism across racial groups in Durham County, NC. J Gen Int Med 31:S191–S192

Schaefer JK et al (2017) Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants. Blood Adv 1(26):2536–2540

Lank RJ et al (2019) Ethnic Differences in 90-Day Poststroke Medication Adherence. Stroke 50(6):1519–1524

O'Brien EC, Holmes ND, Thomas L, Fonarow GC, Kowey PR, Ansell JE, Mahaffey KW, Gersh BJ, Peterson ED, Piccini JP, Hylek EM (2018) J Am Heart Assoc 7(12):e006391

Singh RR et al (2016) Adherence to Anticoagulant Therapy in Pediatric Patients Hospitalized With Pulmonary Embolism or Deep Vein Thrombosis: A Retrospective Cohort Study. Clin Appl Thromb Hemost 22(3):260–264

Yong C, Xu XY, Than C, Ullal A, Schmitt S, Azarbal F, Heidenreich P, Turakhia M (2013) Abstract 14134: racial disparities in warfarin time in INR therapeutic range in patients with atrial fibrillation: Findings from the TREAT-AF Study. Circul 128(22).  https://www.ahajournals.org/doi/10.1161/circ.128.suppl_22.A14134

Chen N, Brooks MM, Hernandez I (2020) Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation. JAMA Netw Open 3(2):e1921357

Pham Nguyen TP et al (2003) Does hospitalization for thromboembolism improve oral anticoagulant adherence in patients with atrial fibrillation? J Am Pharm Assoc 60(6):986-992.e2

Patel AA et al (2013) Persistence of warfarin therapy for residents in long-term care who have atrial fibrillation. Clin Ther 35(11):1794–1804

Golwala H et al (2016) Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Am Heart J 174:29–36

Limdi NA et al (2017) Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users. Pharmacogenet Genomics 27(10):347–355

Lip GY et al (2016) Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT). Am J Cardiol 118(11):1680–1684

Rao SR et al (2015) Explaining racial disparities in anticoagulation control: results from a study of patients at the Veterans Administration. Am J Med Qual 30(3):214–222

Thigpen JL, Yah Q, Beasley M, Limdi NA (2012) Abstract: racial differences in anticoagulation control and risk of hemorrhage among warfarin users. Pharmacoth 32(10):E189

Yong C et al (2016) Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study). Am J Cardiol 117(1):61–68

Moffett BS, Kim S, Bomgaars LR (2013) Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge. Pediatr Blood Cancer 60(9):1503–1506

Rose AJ et al (2013) Gaps in monitoring during oral anticoagulation: insights into care transitions, monitoring barriers, and medication nonadherence. Chest 143(3):751–757

Mahle WT et al (2011) Management of warfarin in children with heart disease. Pediatr Cardiol 32(8):1115–1119

Meade M et al (2011) Impact of health disparities on staff workload in pharmacist-managed anticoagulation clinics. Am J Health Syst Pharm 68(15):1430–1435

Aguilar F et al (2021) Off-label direct oral anticoagulants dosing in atrial fibrillation and venous thromboembolism is associated with higher mortality. Expert Rev Cardiovasc Ther 19(12):1119–1126

Jellinek-Cohen SP, Li M, Husk G (2018) Enoxaparin dosing errors in the emergency department. World J Emerg Med 9(3):195–202

Triller DM et al (2015) Trends in Warfarin Monitoring Practices Among New York Medicare Beneficiaries, 2006–2011. J Community Health 40(5):845–854

Akhtar T et al (2020) Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience. Int J Cardiol 320:78–82

Cires-Drouet RS et al (2022) Prevalence and clinical outcomes of hospitalized patients with upper extremity deep vein thrombosis. J Vasc Surg Venous Lymphat Disord 10(1):102–110

Doucette K et al (2020) Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese. Adv Hematol 2020:3890706

Gu K et al (2021) Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR® PINNACLE Registry. Int J Cardiol 329:209–216

Yamashita Y et al (2018) Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis. Thromb Res 166:37–42

Di Nisio M et al (2016) Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists. Thromb Haemost 115(2):424–432

Hernandez I et al (2015) Risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern Med 175(1):18–24

Majeed A et al (2016) Bleeding events with dabigatran or warfarin in patients with venous thromboembolism. Thromb Haemost 115(2):291–298

Hankey GJ et al (2014) Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke 45(5):1304–1312

Kobayashi L et al (2017) Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial. J Trauma Acute Care Surg 82(5):827–835

Gencer B et al (2022) Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups. Am Heart J 247:24–32

Chen N et al (2021) Joint Latent Class Analysis of Oral Anticoagulation Use and Risk of Stroke or Systemic Thromboembolism in Patients with Atrial Fibrillation. Am J Cardiovasc Drugs 21(5):573–580

Kabra R et al (2015) Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation. Am J Cardiol 116(2):230–235

Kim MH, Xu L, Puckrein G (2018) Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: An Analysis Using Administrative Claims Data. Adv Ther 35(11):2069–2080

Abu-Zeinah G, Oromendia C, DeSancho MT (2019) Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience. J Thromb Thrombolysis 48(2):233–239

Banala SR et al (2017) Discharge or admit? Emergency department management of incidental pulmonary embolism in patients with cancer: a retrospective study. Int J Emerg Med 10(1):19

LaDuke ZJ et al (2019) Association of mortality among trauma patients taking preinjury direct oral anticoagulants versus vitamin K antagonists. Surgery 166(4):564–571

Moreland CJ et al (2013) Anticoagulation education: do patients understand potential medication-related emergencies? Jt Comm J Qual Patient Saf 39(1):22–31

Bamgbade BA et al (2021) Differences in Perceived and Predicted Bleeding Risk in Older Adults With Atrial Fibrillation: The SAGE-AF Study. J Am Heart Assoc 10(17):e019979

Webb D et al (2019) Patient Satisfaction With Venous Thromboembolism Treatment. Clin Appl Thromb Hemost 25:1076029619864663

Kamath CC et al (2021) Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open 4(7):e2116009

U.S. Census Bureau . [cited 2023 10/20/23]; Available from: https://www.census.gov/quickfacts/fact/note/US/RHI625222#:~:text=Asian.,Japan%2C%20Korea%2C%20or%20Vietnam .

Fain KM et al (2021) Race and ethnicity reporting for clinical trials in ClinicalTrials.gov and publications. Contemp Clin Trials 101:106237

American Psychological Association Ethnic and racial minorities & socioeconomic status. 3/22/24]; Available from: https://www.apa.org/pi/ses/resources/publications/minorities#:~:text=The%20relationship%20between%20SES%2C%20race,SES%2C%20race%2C%20and%20ethnicity . Accessed 22 Mar 2024

Braveman PA et al (2010) Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health 100 Suppl 1(Suppl 1):186–96

Wheelock KM et al (2021) Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries. JAMA Netw Open 4(12):e2137288

Barnes GD et al (2015) National Trends in Ambulatory Oral Anticoagulant Use. Am J Med 128(12):1300–5.e2

Iyer GS et al (2023) Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010–2020. JAMA Netw Open 6(3):e234059

MACRA Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). 03/19/24]; Available from: https://www.cms.gov/medicare/quality/value-based-programs/chip-reauthorization-act . Accessed 19 Mar 2024

Blueprint Measure Lifecycle Overview. 03/19/2024]; Available from: https://mmshub.cms.gov/blueprint-measure-lifecycle-overview . Accessed 19 Mar 2024

Endorsement and Maintenance (E&M) Guidebook. 3/19/24]; Available from: https://p4qm.org/sites/default/files/2023-12/Del-3-6-Endorsement-and-Maintenance-Guidebook-Final_0_0.pdf . Accessed 19 Mar 2024

Measure Implementation. 3/19/24]; Available from: https://mmshub.cms.gov/measure-lifecycle/measure-implementation/selection . Accessed 19 Mar 2024

Download references

Acknowledgements

The authors wish to acknowledge the following individuals for their work in screening articles for this scoping review: April Allen, PharmD, CACP; Allison Burnett, PharmD, PhC, CACP; Stacy Ellsworth, RN, MSN, CCRC; Danielle Jenkins, MBA, RN, BSN, CRNI; Amanda Katz, MBA; Lea Kistenmacher, Julia Mulheman, PharmD; Surhabi Palkimas, PharmD, MBA; Terri Schnurr, RN, CCRC; Deborah Siegal, MD, MSc, FRCPC; Kimberly Terry, PharmD, BCPS, BCCCP; and Terri Wiggins, MS.

The authors wish to acknowledge the support of the Anticoagulation Forum in the development of this manuscript. The Anticoagulation Forum is a non-profit organization dedicated to improving the quality of care for patients taking antithrombotic medications.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and affiliations.

University of Utah Health Thrombosis Service, 6056 Fashion Square Drive, Suite 1200, Murray, UT, 84107, USA

Sara R. Vazquez

Kaiser Permanente Clinical Pharmacy Services, 200 Crescent Center Pkwy, Tucker, GA, 30084, USA

Naomi Y. Yates

Anticoagulation Forum, Inc, 17 Lincoln Street, Suite 2B, Newton, MA, 02461, USA

Craig J. Beavers & Darren M. Triller

University of Kentucky College of Pharmacy, 789 S Limestone, Lexington, KY, 40508, USA

Craig J. Beavers

University of Utah Spencer S. Eccles Health Sciences Library, 10 N 1900 E, Salt Lake City, UT, 84112, USA

Mary M. McFarland

You can also search for this author in PubMed   Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation was performed by Sara Vazquez, Naomi Yates, and Mary McFarland. Data collection and analysis were performed by Sara Vazquez, Naomi Yates, Craig Beavers, and Darren Triller. The first draft of the manuscript was written by Sara Vazquez and all authors edited subsequent drafts. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Sara R. Vazquez .

Ethics declarations

Competing interests.

Dr. Vazquez discloses that she is a member of the Anticoagulation Forum Advisory Council and an editorial consultant for UptoDate, Inc.

Dr. Yates has no conflicts of interest to disclose.

Dr. Beavers has no conflicts of interest to disclose.

Dr. Triller has no conflicts of interest to disclose.

Ms. McFarland has no conflicts of interest to disclose.

Additional information

Publisher's note.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 22 KB)

Supplementary file2 (docx 14 kb), rights and permissions.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ .

Reprints and permissions

About this article

Vazquez, S.R., Yates, N.Y., Beavers, C.J. et al. Differences in quality of anticoagulation care delivery according to ethnoracial group in the United States: A scoping review. J Thromb Thrombolysis (2024). https://doi.org/10.1007/s11239-024-02991-2

Download citation

Accepted : 27 April 2024

Published : 11 May 2024

DOI : https://doi.org/10.1007/s11239-024-02991-2

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

• Ethnoracial
• Disparities
• Anticoagulation
• Find a journal
• Publish with us
• Track your research

Purdue Online Writing Lab Purdue OWL® College of Liberal Arts

Welcome to the Purdue Online Writing Lab

Welcome to the Purdue OWL

This page is brought to you by the OWL at Purdue University. When printing this page, you must include the entire legal notice.

Copyright ©1995-2018 by The Writing Lab & The OWL at Purdue and Purdue University. All rights reserved. This material may not be published, reproduced, broadcast, rewritten, or redistributed without permission. Use of this site constitutes acceptance of our terms and conditions of fair use.

The Online Writing Lab at Purdue University houses writing resources and instructional material, and we provide these as a free service of the Writing Lab at Purdue. Students, members of the community, and users worldwide will find information to assist with many writing projects. Teachers and trainers may use this material for in-class and out-of-class instruction.

The Purdue On-Campus Writing Lab and Purdue Online Writing Lab assist clients in their development as writers—no matter what their skill level—with on-campus consultations, online participation, and community engagement. The Purdue Writing Lab serves the Purdue, West Lafayette, campus and coordinates with local literacy initiatives. The Purdue OWL offers global support through online reference materials and services.

A Message From the Assistant Director of Content Development 

The Purdue OWL® is committed to supporting  students, instructors, and writers by offering a wide range of resources that are developed and revised with them in mind. To do this, the OWL team is always exploring possibilties for a better design, allowing accessibility and user experience to guide our process. As the OWL undergoes some changes, we welcome your feedback and suggestions by email at any time.

Please don't hesitate to contact us via our contact page  if you have any questions or comments.

All the best,

Social Media

Facebook twitter.